Outsourcing Pharma

SEPTEMBER 22, 2021

SmartSignals Supplies is designed to help trial teams get a handle on clinical trial supply chain management to avoid delays, waste, and cost overruns.

Clinical Supply Chain 69

Clinical Supply Chain Clinical Supply Clinical Trials Clinical Trials 69

Pharmaceutical Technology

MAY 24, 2023

Nearly every biopharma with a portfolio of drugs in development spanning traditional small molecules and biologics and the newer CGT operates with separate clinical supply organizations per these therapy areas. This is due to major differences throughout the clinical supply chain in both requirements and management practices.

Clinical Trials 246

Clinical Trials Clinical Trials Gene Therapy Clinical Supply Chain 246

The Pharma Data

SEPTEMBER 14, 2020

Supply chain uncertainty is a challenge every clinical supply chain manager wrestles with – stemming from increasing product demand and quality, the growing complexity of clinical trial designs and a lack of visibility in the supply chain.

Clinical Supply Chain 52

Clinical Supply Chain Clinical Supply Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 4, 2021

company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in clinical trials. (AWS), an Amazon.com, Inc.

Manufacturing 52

Manufacturing Development Drugs Clinical Supply Chain 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.

Clinical Supply

XTalks

JULY 24, 2023

Many third-party supply chain solutions exist in the market, but none have the full suite offerings available in Surgence,” said Cody Fisher, Concordance EVP and strategic advisor in the company’s news release.

Clinical Supply Chain 92

Clinical Supply Chain Clinical Supply Production Marketing 92

XTalks

JUNE 16, 2023

Concerningly, the survey also revealed that only 40 percent of the surveyed NCCN cancer centers received any indication from manufacturers or suppliers about when carboplatin or cisplatin would be readily available again. These drugs are often generics and hence have a low unit price, making them less appealing to manufacturers.

Drugs 98

Drugs Manufacturing Clinical Supply Chain Clinical Trials 98